Advertisement

Topics

"Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients" Drugs and Medication Database

16:44 EST 17th February 2019 | BioPortfolio

Here are the most relevant "Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients" Drugs and Medications that we have found in our database.

More Information about "Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients" on BioPortfolio

We have published hundreds of Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients news stories on BioPortfolio along with dozens of Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients Clinical Trials and PubMed Articles about Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients Companies in our database. You can also find out about relevant Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients Drugs and Medications on this site too.

Showing "Safety Human Lactoferrin hLF1 Treatment Infectious Complications Among" Drugs and Medications, all 4

Possibly Relevant

Mytesi [napo pharmaceuticals, inc.]

These highlights do not include all the information needed to use MYTESI safely and effectively . See full prescribing information for MYTESI.       MYTESI (crofelemer) delayed-release tablets for oral use      Initial U.S. Approval: 2012

Diphenoxylate hydrochloride and atropine sulfate [redpharm drug, inc.]

diphenoxylate/atropine

Ethamolin [qol medical, llc.]

Ethamolin® (Ethanolamine Oleate) Injection, 5%. For Local Intravenous Use OnlyRx only

Aplisol [tya pharmaceuticals]

APLISOL (Tuberculin Purified Protein Derivative, Diluted [Stabilized Solution])



Advertisement
Quick Search
Advertisement
Advertisement